The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

The US Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women.

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

Visby Medical Women’s Sexual Health Test can be taken by those with or without symptoms,and delivers results in about 30 minutes.

This is the first diagnostic test for chlamydia, gonorrhea and trichomoniasis that can be purchased without a prescription ...

The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...

The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...

The FDA has granted marketing authorization to Visby Medical for the first at-home diagnostic test for chlamydia, gonorrhea and trichomoniasis that does not require a prescription. The test includes a ...

The US Food and Drug Administration (FDA) has authorised the first at-home PCR STI test for chlamydia, gonorrhoea, and ...

President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ...

Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and ...